glp-1 venus williams Serena's return to competitive play puts sporting spotlight on GLP-1s EXCLUSIVE: Serena Williams has been

In clinical trials, which compared people randomly assigned to the active drug or a placebo, participants receiving semaglutide or tirzepatide lost 15% to 20% of their body weight on average

These medications don't just change how much people eatthey fundamentally alter the relationship with food itself

Novo Nordisk Announces Significant Price Drops for Popular GLP-1 Medications Mike Hollan Key Takeaways Novo Nordisk will set a $675/month US list price (effective January 1, 2027) for Wegovy, Ozempic, and Rybelsus, targeting affordability for high-deductible and coinsurance designs

These medications affect areas of the brain that control appetite, satiety, and reward

But you might also be noticing something else